Exollence Co., Ltd.
- Biotech or pharma, therapeutic R&D
Exollence is a biotech company developing siRNA therapeutics and mRNA vaccines using its proprietary SWEET™ platform, which enables efficient loading of siRNA, mRNA, and proteins into extracellular vesicles (EVs). The platform supports targeted delivery for cancer and gene therapies, and is also applied in cosmetics to improve skin absorption and stability.